Prophylactic and therapeutic parotidectomy for secondary neoplasms of the parotid gland

Abstract

ABSTRACTObjectives: The aim of this study was to review the demographic and clinicopathological findings of thepatients who underwent prophylactic or therapeutic parotidectomy due to the secondary neoplasm of the parotidgland (SNP), the outcomes of the patients with SNP and to provide a perspective to the parotid and neckapproach in head and neck skin cancer cases.Methods: The clinical data of 178 patients who underwent parotidectomydue to neoplasm in the Departmentof Otorhinolaryngology, Head and Neck Surgery of a tertiary referral center from 2012 to 2017 were reviewed.Results: Among 178 patients, twenty-two (12.4%) patients were found to underwentprophylactic or therapeuticparotidectomy due to SNP. Six of these patients had pathologically positive parotid metastases (therapeuticparotidectomy). The median age of six patients was 67 years (ranging from 2 to 83 years). Five patients weremale and one was female. The most common indication of parotidectomy (prophylactic and therapeutic) andpathology of parotid mass due to SNP and Cutaneous Squamous Cell Carcinoma (SCC) (36.3% and 50%,respectively).Conclusions: Owing to rapidly progressive feature and high morbidity, close observation of parotid in case ofmetastasis is crucial for recurrent SCC of the face and scalp.